Summary
Danaher Corporation (DHR) filed an 8-K on December 11, 2009, to report a change in its Board of Directors. The key event is the appointment of Elias A. Zerhouni, M.D., to fill a vacancy on the Board. Dr. Zerhouni's initial term will extend until Danaher's 2011 annual meeting of shareholders. Investors should note that Dr. Zerhouni is being appointed as a non-employee director and will receive compensation consistent with other non-employee directors, as previously outlined in the company's proxy statement. The filing also confirms that there are no undisclosed arrangements or transactions involving Dr. Zerhouni that require specific disclosure, suggesting a standard and straightforward board appointment.
Key Highlights
- 1Danaher Corporation appointed Elias A. Zerhouni, M.D., to its Board of Directors on December 8, 2009.
- 2Dr. Zerhouni's appointment fills a current vacancy on the Board.
- 3His initial term as a director will conclude at the company's 2011 annual shareholder meeting.
- 4Dr. Zerhouni will serve as a non-employee director.
- 5His compensation will be in line with that of other non-employee directors.
- 6No undisclosed arrangements or material transactions requiring disclosure under Regulation S-K exist between Dr. Zerhouni and Danaher.
- 7The appointment is effective as of the date of the Board's decision, December 8, 2009.
Frequently Asked Questions
Elias A. Zerhouni, M.D., has been appointed to Danaher's Board of Directors.
Dr. Zerhouni was appointed on December 8, 2009, and his initial term will expire at Danaher's 2011 annual meeting of shareholders.
As a non-employee director, Dr. Zerhouni will receive the standard compensation paid to other non-employee directors, as disclosed in Danaher's annual proxy statement.
The filing states there are no arrangements or understandings for his selection, nor any transactions requiring disclosure under Item 404(a) of Regulation S-K, indicating a standard board appointment without apparent conflicts.